Purity:98% HPLC
Packing:2mg/vial and 5mg/vial;10vials/box
Min Order: 1box
Payment:Bitcoin,Moneygram and Wester Union
Lead time:24hours after received payment
Safe shipping to US and most of Europe country
Storage:Shading, confined preservation,2-8°C
Retatrutide, number LY-3437943, is arguably the latest promising drug for weight loss and the treatment of type 2 diabetes in obese/overweight patients. It has a completely new mode of action, and clinical trials have shown that it is more effective in weight loss than the FDA-approved Semagelutide(Wegovy) and Tirzepatide(Mounjaro). Perhaps you have not heard of this new weight loss peptide, today we will introduce it -Retatrutide.
What is peptides Retatrutide LY-3437943?
For sale Retatrutide LY-3437943 basic information:
Cas No.:2381089-83-2
MF:C223H343F3N46O70
MW: 4845.444
Some approved weight loss products were originally developed to treat type 2 diabetes and work based on things like appetite control and delayed gastric empting. Retatrutide, a new drug in development for the treatment of obesity, is a triple receptor agonist that activates the GLP-1(glucagon-like peptide-1) receptor,GIP(Glucose-dependent insulin stimulating) receptor and GCGR (glucagon) receptors in the body, an unprecedented way to lose weight.
How does Retatrutide lose weight?
A preliminary understanding of how Retatrutide works for weight loss can be found in the three receptors it acts on.
GLP-1: Glucagon-like peptide 1
GLP-1 is the key word in the treatment of type 2 diabetes, which mainly plays a role in regulating blood sugar in the body. it inhibits appetite and slows stomach emptying, helping to lower blood sugar while also helping with weight loss, which is why drugs used to treat type 2 diabetes can also be used for weight loss.
GIP: Glucose-dependent insulin-promoting polypeptide
GIP, also known as gastric inhibitory peptides, reduces hunger and increases satiety by reducing the secretion of stomach acid and the speed at which food is transported through the stomach.
